As so-called lysosomotropes have been found to be neuroprotective [26], we wanted to determine if the DAQ-DcpS inhibitors could show therapeutic benefit for SMA mice without accumulating to the lysosome. The gene discussed is DCPS; the disease is proximal spinal muscular atrophy.